Clinical Trials
Several clinical trials are currently recruiting participants across diverse indications, including Alzheimer's disease, cognitive impairment, localized prostate carcinoma, traumatic rib fractures with acute or chronic pain, and postoperative pain tracking via smart device applications. Sponsored by academic and clinical entities such as C2N Diagnostics, IRCCS San Raffaele, Sunnybrook Health Sciences Centre, and Seoul National University Hospital, all studies report trial phases as unassigned or not applicable.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06025877 | Recruiting | Alzheimer Disease|Mild Cognitive Impairment|Dementia|Cognitive Decline|Cognitive Impairment|Memory Impairment |
C2N Diagnostics |
2023-11-15 | -- |
| NCT05936736 | Recruiting | Localized Prostate Carcinoma |
IRCCS San Raffaele |
2023-11-08 | Not Applicable |
| NCT05865327 | Recruiting | Rib Fractures|Rib Fracture Multiple|Rib; Fracture With Flail Chest|Pain|Pain Acute|Pain Chronic|Trauma|Trauma Injury |
Sunnybrook Health Sciences Centre |
2023-10-23 | Not Applicable |
| NCT06014918 | Recruiting | Mobile Applications|Pain Postoperative|Smartphone|Patient Satisfaction |
Seoul National University Hospital |
2023-08-28 | Not Applicable |
(data from https://clinicaltrials.gov, updated on 2024-05-22)
Check the
Aluminum potassium sulfate
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Compliance for Clinical Use
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Jump to
- Aluminum potassium sulfate Solubility in DMSO
- Aluminum potassium sulfate Stock Solution
- Aluminum potassium sulfate Storage
- Aluminum potassium sulfate Stability
- Aluminum potassium sulfate Molecular Weight
- Aluminum potassium sulfate CAS Number
- Aluminum potassium sulfate Chemical Structure (2D and 3D)
- Aluminum potassium sulfate SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.